Prevalence of human T cell leukaemia virus amongst blood donors

Medical Journal Armed Forces India

Volumn 65, Issue 1, 2009, Pages 38-40

  Chaudhari, C N ^a   Shah, T ^a   Misra, R N ^b  

^a INHS Jeevanti ^*  (India)

^b INHS Kalyani   (India)

Author keywords

Blood donors; HTLV I II; Retrovirus; Transfusion transmitted infection

Indexed keywords

FRESH FROZEN PLASMA; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; BURN; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 70349215499     PISSN: 03771237     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0377-1237(09)80052-X     Document Type: Article

References (24)

1. Fischer HE. Human T-Lymphotropic Virus Types I and II: Screening and Sero-prevalence in Blood Donors. Current issues in Transfusion Medicine 1995; 3(4). Available from http://www.mdacc.tmc.edu/~citm.
2. Pagliuca A, Pawson R, Mufti GJ. HTLV-1 screening in Britain. Br Med J 1995; 311:1313-4.
3. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24:6058-68.
4. Stigum H, Magnus P, Samdal HH, Nord E. Human T -cell lymphotrophic virus testing of blood donors in Norway: a cost-effect model. Int J Epidemiol 2000;29:1076-84.
5. Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD. Transmission of human T-lymphotropic virus types I and II by blood transfusion: a retrospective study of recipients of blood components (1983 through 1988): The American Red Cross HTLV-I/II Collaborative Study Group. Arch Intern Med 1991; 151: 2043-8.
6. Donegan E, Lee H, Operskalski EA, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 1994; 34: 478-83.
7. Chen YC, Wang CH, Su IJ, et al. Infection of human T-cell leukaemia virus type I and development of human T-cell leukemia lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion. Blood 1989; 74: 388-94.
8. Morris JC, Janik JE, Turner M, et al. A phase I/II study of the efficacy and toxicity of humanised anti-Tac for the treatment of Tac-expressing human lymphotropic virus type I -associated adult T-cell leukaemia/ lymphoma (ATL): interim results. AIDS research and human retroviruses 2001; 17 (suppl 1): S29.
9. Tynell E. Prevention of transfusion transmitted infections. Donor screening and characteristics of recipient populations (Thesis). Stockholm, Karolinska University:2005.
10. Inaba S, Okochi K, Sato H, et al. Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection. Transfusion 1999; 39: 1104-10.
11. Ramalingam S, Kannangai R, Prakash KJ, et al. A pilot study of HTLV-I infection in high-risk individuals & their family members from India. Indian J Med Res 2001; 113:201-9.
12. Babu PG, Ishida T, Nesadoss J, John TJ. Prevalence of HTLVI/II antibodies in HIV seropositive and HIV seronegative STD patients in Vellore region in southern India. Scand J Infect Dis 1995; 27:105-8.
13. Malhotra VL, Lakshmy A. HTLV-I in HIV seropositive Indian blood donors. J Commun Dis 1996; 28: 270-2.
14. Oomman A, Madhusoodanan M. Tropical spastic paraparesis in Kerala. Neurol India 2003;51:493-6.
15. Ajithkumar K, Ramalingam S, Kannangai R, Prakash KJ. Human T lymphotrophic virus-I (HTLV-I) infection in patients with unclassifiable dermatitis in central Kerala, South India: a preliminary study. Sex Transm Infect 2002;78:E7
16. Varma M, Mehta G. Incidence of HTLV-I in high risk population in Delhi. J Commun Dis 1999; 31: 237-40.
17. Kelkar R, Ishida T, Bharucha Z, Advani SH, Hayame M. A seroepidemiological survey of HTLV in blood donors in India. Ind J Haematol Blood Trans 1990;8:11-4.
18. Sikka M, Rusia U, Madan N, Singh B. Screening for Antibodies to HTLV -1 in blood donors: a preliminary study. Ind J Haematol Blood Trans 1996; 14: 92-4.
19. Kumar H, Gupta PK. Is seroprevalence of HTLV I/II among blood donors in India relevant? Ind J Pathol Microbiol 2006; 49:532-4.
20. Ohkura S, Yamashita M, Ishida T, et al. Phylogenetic heterogeneity of new HTLV type 1 isolates from southern India in subgroup A. AIDS Res Hum Retroviruses 2005;21: 325-30.
21. Catalam Soares B, Carneiro-Proietti AB, Proietti FA. Heterogeneous geographic distribution of human T-cell lymphotrophic viruses I and II (HTLVI/II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cads Saude Publica 2005; 21: 926-31.
22. Maeda Y, Furukawa M, Takehara Y, et al. Prevalence of possible adult T-cell leukaemia virus carriers among volunteer blood donors in Japan: a nation wide study. Int J cancer 1984; 33:717-20.
23. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322: 383-8.
24. Raghavan M, Marik PE. Anemia, Allogenic Blood Transfusion, and Immunomodulation in the Critically Ill. Chest 2005; 127: 295-307.